Posted On: 12/12/2013 2:34:10 PM
Post# of 94313
$CYTR Company News
CytRx's stock spike proves to be no fluke with another 20% share gain 11:39 a.m. Today - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 4:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 10:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 9:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 5:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 7:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 10:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 11:49 a.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 10:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 1:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 8:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 1:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx halts trial of ALS treatment 7:50 a.m. Jan. 22, 2008 - Angela Moore
FDA puts hold on CytRx's Phase IIb arimoclomol trial 7:34 a.m. Jan. 22, 2008 - Michael Kitchen
CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase 2B Tests 12:28 p.m. Today - Seeking Alpha
CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase IIB Tests 12:28 p.m. Today - Seeking Alpha
Perilous Reversal Watch: CytRx Corporation (CYTR) 9:55 a.m. Today - TheStreet.com
CytRx Corporation Soars on Positive Phase 2b Sarcoma Data 1:38 p.m. Dec. 11, 2013 - Wall St. Cheat Sheet
Why CytRx (CYTR) Is Exploding on Wednesday 1:32 p.m. Dec. 11, 2013 - TheStreet.com
CytRx's Sarcoma Treatment Shows Positive Results 9:48 a.m. Dec. 11, 2013 - WSJ.com
Morning Market Movers 8:56 a.m. Dec. 11, 2013 - benzinga.com
CytRx reports positive top-line data from aldoxorubicin STS trial 8:23 a.m. Dec. 11, 2013 - Seeking Alpha
CytRx Corporation Offers Hope for Brain Cancer Patients 11:23 a.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Top Insider Trades: CYTR TROX KTOS MDGN 9:50 a.m. Dec. 4, 2013 - TheStreet.com
CytRx rallies after conference presentation 8:19 a.m. Dec. 4, 2013 - Seeking Alpha
Aegis still positive on CytRx, sees big upside 9:50 a.m. Nov. 25, 2013 - Seeking Alpha
CytRx Initiates Phase 2 Aldoxorub Trial in Patients with Unresectable GBM Brain Cancer 7:40 a.m. Nov. 20, 2013 - benzinga.com
A Small Cap That is Cashing In on ObamaCare 3:44 p.m. Nov. 19, 2013 - benzinga.com
Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment 10:40 a.m. Nov. 19, 2013 - Seeking Alpha
CytRx Surges Ahead With Positive Drug Data 7:41 a.m. Nov. 1, 2013 - Seeking Alpha
CytRx Announces Further Positive Clinical Data from Global Phase 2b Aldoxorubicin Study 5:03 a.m. Oct. 31, 2013 - benzinga.com
10-Q: CYTRX CORP 6:02 a.m. Oct. 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
CytRx Says Wins FDA Acceptance for Protocol of Phase 2 Aldoxorubicin in Glioblastoma Trial 7:36 a.m. Oct. 23, 2013 - benzinga.com
CytRx Awaiting Soft Tissue Sarcoma Data In December 8:56 a.m. Oct. 17, 2013 - Seeking Alpha
Bullish Stocks Radar: CytRx Corporation, Echo Therapeutics Inc, Advanced Micro Devices, Inc, Baidu Inc 9:02 a.m. Dec. 11, 2013 - ACCESSWIRE
CytRx Reports Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial 8:17 a.m. Dec. 11, 2013 - BusinessWire
CytRx to Hold Conference Call December 11, 2013 at 10:30 a.m. Eastern Time to Discuss Results of Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas 5:30 p.m. Dec. 10, 2013 - BusinessWire
CytRx Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11th, 2013 8:30 a.m. Dec. 4, 2013 - BusinessWire
CytRx to Present at the Sixth Annual LD MICRO "Main Event" Conference in Los Angeles on December 3, 2013 8:30 a.m. Nov. 26, 2013 - BusinessWire
CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme (Brain Cancer) 8:30 a.m. Nov. 20, 2013 - BusinessWire
MissionIR Releases Exclusive Audio Interview With CytRx Management 8:31 a.m. Nov. 7, 2013 - Marketwire
CytRx Reports Further Positive Interim Data from Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas 5:00 a.m. Oct. 31, 2013 - BusinessWire
CytRx Reports 2013 Third Quarter Financial Results 5:00 a.m. Oct. 29, 2013 - BusinessWire
Hot Topic: Breast Cancer Awareness Month 2013 7:08 a.m. Oct. 25, 2013 - BusinessWire
CytRx Announces Closing of Public Offering of Common Stock 11:45 a.m. Oct. 15, 2013 - BusinessWire
CytRx Announces Exercise of Underwriters' Over-Allotment Option 6:00 p.m. Oct. 11, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
CytRx Announces Pricing of Public Offering of 10.0 Million Shares of Common Stock 8:15 p.m. Oct. 8, 2013 - BusinessWire
CytRx Announces Proposed Public Offering of Common Stock 3:20 p.m. Oct. 8, 2013 - BusinessWire
OtcbbJournal.com, Where Savvy Traders Get Their Small-Cap Stock Research 7:02 a.m. Sept. 30, 2013 - Marketwire
CytRx's New Aldoxorubicin Data Demonstrates Significant Advantages over Doxorubicin 5:00 a.m. Sept. 30, 2013 - BusinessWire
CytRx to Present at the Aegis Capital Corp. 2013 Healthcare Conference 7:30 a.m. Sept. 23, 2013 - BusinessWire
CytRx to Present at the Rodman & Renshaw Global Investment Conference 7:30 a.m. Sept. 3, 2013 - BusinessWire
CytRx Reports 2013 Second Quarter Financial Results 7:30 a.m. Aug. 6, 2013 - BusinessWire
CytRx's stock spike proves to be no fluke with another 20% share gain 11:39 a.m. Today - Russ Britt
MasterCard, Visa among top S&P gainers; Avon in red 4:27 p.m. Dec. 11, 2013 - Sue Chang
Cancer drug test results send CytRx shares soaring by 75% 10:48 a.m. Dec. 11, 2013 - Russ Britt
CytRx jumps on results of aldoxorubicin trial 9:47 a.m. Dec. 11, 2013 - MarketWatch.com
Yum shares drop on outlook, soft China sales 5:10 p.m. Oct. 8, 2013 - Wallace Witkowski
Six companies unveil share, unit offerings 7:45 a.m. Dec. 7, 2012 - MarketWatch.com
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
CytRx prices offering at 20% discount 10:07 a.m. Oct. 18, 2012 - MarketWatch.com
CytRx down 20.6% in premarket 7:59 a.m. Oct. 18, 2012 - Steve Gelsi
CytRx rallies 27% on drug study update 11:49 a.m. July 25, 2012 - Val Brickates Kennedy
CytRx falls 12% in morning trading 10:02 a.m. June 4, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining and declining stocks 3:40 p.m. April 28, 2011 - Kate Gibson
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:00 p.m. June 30, 2009 - MarketWatch
Drug stocks retract; Vical, Geron, Novavax soar 1:29 p.m. June 30, 2009 - Val Brickates Kennedy
CytRx files FDA report on halted clinical trial 8:16 a.m. June 30, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 4:39 p.m. Jan. 22, 2008 - MarketWatch
Drug stocks tumble on U.S. economy jitters; CytRx slumps 1:33 p.m. Jan. 22, 2008 - Val Brickates Kennedy
CytRx halts trial of ALS treatment 7:50 a.m. Jan. 22, 2008 - Angela Moore
FDA puts hold on CytRx's Phase IIb arimoclomol trial 7:34 a.m. Jan. 22, 2008 - Michael Kitchen
CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase 2B Tests 12:28 p.m. Today - Seeking Alpha
CytRx Surges As Aldoxorubicin Dominates Doxorubicin In Phase IIB Tests 12:28 p.m. Today - Seeking Alpha
Perilous Reversal Watch: CytRx Corporation (CYTR) 9:55 a.m. Today - TheStreet.com
CytRx Corporation Soars on Positive Phase 2b Sarcoma Data 1:38 p.m. Dec. 11, 2013 - Wall St. Cheat Sheet
Why CytRx (CYTR) Is Exploding on Wednesday 1:32 p.m. Dec. 11, 2013 - TheStreet.com
CytRx's Sarcoma Treatment Shows Positive Results 9:48 a.m. Dec. 11, 2013 - WSJ.com
Morning Market Movers 8:56 a.m. Dec. 11, 2013 - benzinga.com
CytRx reports positive top-line data from aldoxorubicin STS trial 8:23 a.m. Dec. 11, 2013 - Seeking Alpha
CytRx Corporation Offers Hope for Brain Cancer Patients 11:23 a.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Top Insider Trades: CYTR TROX KTOS MDGN 9:50 a.m. Dec. 4, 2013 - TheStreet.com
CytRx rallies after conference presentation 8:19 a.m. Dec. 4, 2013 - Seeking Alpha
Aegis still positive on CytRx, sees big upside 9:50 a.m. Nov. 25, 2013 - Seeking Alpha
CytRx Initiates Phase 2 Aldoxorub Trial in Patients with Unresectable GBM Brain Cancer 7:40 a.m. Nov. 20, 2013 - benzinga.com
A Small Cap That is Cashing In on ObamaCare 3:44 p.m. Nov. 19, 2013 - benzinga.com
Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment 10:40 a.m. Nov. 19, 2013 - Seeking Alpha
CytRx Surges Ahead With Positive Drug Data 7:41 a.m. Nov. 1, 2013 - Seeking Alpha
CytRx Announces Further Positive Clinical Data from Global Phase 2b Aldoxorubicin Study 5:03 a.m. Oct. 31, 2013 - benzinga.com
10-Q: CYTRX CORP 6:02 a.m. Oct. 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
CytRx Says Wins FDA Acceptance for Protocol of Phase 2 Aldoxorubicin in Glioblastoma Trial 7:36 a.m. Oct. 23, 2013 - benzinga.com
CytRx Awaiting Soft Tissue Sarcoma Data In December 8:56 a.m. Oct. 17, 2013 - Seeking Alpha
Bullish Stocks Radar: CytRx Corporation, Echo Therapeutics Inc, Advanced Micro Devices, Inc, Baidu Inc 9:02 a.m. Dec. 11, 2013 - ACCESSWIRE
CytRx Reports Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial 8:17 a.m. Dec. 11, 2013 - BusinessWire
CytRx to Hold Conference Call December 11, 2013 at 10:30 a.m. Eastern Time to Discuss Results of Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas 5:30 p.m. Dec. 10, 2013 - BusinessWire
CytRx Corporation to Present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11th, 2013 8:30 a.m. Dec. 4, 2013 - BusinessWire
CytRx to Present at the Sixth Annual LD MICRO "Main Event" Conference in Los Angeles on December 3, 2013 8:30 a.m. Nov. 26, 2013 - BusinessWire
CytRx Initiates Phase 2 Clinical Trial with Aldoxorubicin in Patients with Unresectable Glioblastoma Multiforme (Brain Cancer) 8:30 a.m. Nov. 20, 2013 - BusinessWire
MissionIR Releases Exclusive Audio Interview With CytRx Management 8:31 a.m. Nov. 7, 2013 - Marketwire
CytRx Reports Further Positive Interim Data from Global Phase 2b Clinical Trial with Aldoxorubicin versus Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas 5:00 a.m. Oct. 31, 2013 - BusinessWire
CytRx Reports 2013 Third Quarter Financial Results 5:00 a.m. Oct. 29, 2013 - BusinessWire
Hot Topic: Breast Cancer Awareness Month 2013 7:08 a.m. Oct. 25, 2013 - BusinessWire
CytRx Announces Closing of Public Offering of Common Stock 11:45 a.m. Oct. 15, 2013 - BusinessWire
CytRx Announces Exercise of Underwriters' Over-Allotment Option 6:00 p.m. Oct. 11, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
CytRx Announces Pricing of Public Offering of 10.0 Million Shares of Common Stock 8:15 p.m. Oct. 8, 2013 - BusinessWire
CytRx Announces Proposed Public Offering of Common Stock 3:20 p.m. Oct. 8, 2013 - BusinessWire
OtcbbJournal.com, Where Savvy Traders Get Their Small-Cap Stock Research 7:02 a.m. Sept. 30, 2013 - Marketwire
CytRx's New Aldoxorubicin Data Demonstrates Significant Advantages over Doxorubicin 5:00 a.m. Sept. 30, 2013 - BusinessWire
CytRx to Present at the Aegis Capital Corp. 2013 Healthcare Conference 7:30 a.m. Sept. 23, 2013 - BusinessWire
CytRx to Present at the Rodman & Renshaw Global Investment Conference 7:30 a.m. Sept. 3, 2013 - BusinessWire
CytRx Reports 2013 Second Quarter Financial Results 7:30 a.m. Aug. 6, 2013 - BusinessWire
(0)
(0)
